Literature DB >> 9391123

Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice.

H Su1, R Lu, J C Chang, Y W Kan.   

Abstract

About 70% of hepatocellular carcinomas are known to express alpha-fetoprotein, which is normally expressed in fetal but not in adult livers. To induce herpes simplex virus-thymidine kinase expression in these cancer cells, we constructed an adeno-associated viral vector containing the HSV-TK gene under the control of the alpha-fetoprotein enhancer and albumin promoter. We previously demonstrated in vitro that although this vector can transduce a variety of human cells, only transduced AFP and albumin-expressing hepatocellular carcinoma cell lines were sensitive to killing by ganciclovir (GCV). In the present study, we explored the effect of this vector on hepatocellular carcinoma cells in vivo. Subcutaneous tumors generated in nude mice by implanting hepatocellular carcinoma cells previously transduced with this vector shrank dramatically after treatment with GCV. Bystander effect was also observed on the tumors generated by mixing transduced and untransduced cells. To test whether the tumor cells can be transduced by the virus in vivo, we injected the recombinant adeno-associated virus into tumors generated by untransduced hepatocarcinoma cell line. Tumor growth were retarded after treatment with GCV. These experiments demonstrate the feasibility of in vivo transduction of tumor cell with rAAV.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9391123      PMCID: PMC28403          DOI: 10.1073/pnas.94.25.13891

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase.

Authors:  W Y Chen; E C Bailey; S L McCune; J Y Dong; T M Townes
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

2.  A position-dependent silencer plays a major role in repressing alpha-fetoprotein expression in human hepatoma.

Authors:  H Nakabayashi; T Hashimoto; Y Miyao; K K Tjong; J Chan; T Tamaoki
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

3.  Thymidine kinase obliteration: creation of transgenic mice with controlled immune deficiency.

Authors:  R A Heyman; E Borrelli; J Lesley; D Anderson; D D Richman; S M Baird; R Hyman; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

4.  Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression.

Authors:  R J Samulski; L S Chang; T Shenk
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

5.  Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors.

Authors:  F L Moolten; J M Wells
Journal:  J Natl Cancer Inst       Date:  1990-02-21       Impact factor: 13.506

6.  Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells.

Authors:  Y Takamiya; M P Short; Z D Ezzeddine; F L Moolten; X O Breakefield; R L Martuza
Journal:  J Neurosci Res       Date:  1992-11       Impact factor: 4.164

7.  Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy.

Authors:  B E Huber; C A Richards; T A Krenitsky
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

8.  Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene.

Authors:  Z D Ezzeddine; R L Martuza; D Platika; M P Short; A Malick; B Choi; X O Breakefield
Journal:  New Biol       Date:  1991-06

9.  In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.

Authors:  K W Culver; Z Ram; S Wallbridge; H Ishii; E H Oldfield; R M Blaese
Journal:  Science       Date:  1992-06-12       Impact factor: 47.728

10.  Establishment of a continuously growing cell line from primary carcinoma of the liver.

Authors:  J J Alexander; E M Bey; E W Geddes; G Lecatsas
Journal:  S Afr Med J       Date:  1976-12-18
View more
  12 in total

1.  Gene therapy vectors harboring AFP regulatory sequences. Preparation of an adenoviral vector.

Authors:  S Kaneko; T Tamaoki
Journal:  Mol Biotechnol       Date:  2001-11       Impact factor: 2.695

2.  A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy.

Authors:  H Ruan; H Su; L Hu; K R Lamborn; Y W Kan; D F Deen
Journal:  Neoplasia       Date:  2001 May-Jun       Impact factor: 5.715

Review 3.  Treatment of human disease by adeno-associated viral gene transfer.

Authors:  Kenneth H Warrington; Roland W Herzog
Journal:  Hum Genet       Date:  2006-04-13       Impact factor: 4.132

4.  Upstream region of rat serum albumin gene promoter contributes to promoter activity: presence of functional binding site for hepatocyte nuclear factor-3.

Authors:  C H Hsiang; N W Marten; D S Straus
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

5.  TK gene combined with mIL-2 and mGM-CSF genes in treatment of gastric cancer.

Authors:  Shan-Yu Guo; Qin-Long Gu; Zheng-Gang Zhu; He-Qun Hong; Yan-Zhen Lin
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

6.  Utilizing alpha-fetoprotein expression to enhance oncolytic viral therapy in hepatocellular carcinoma.

Authors:  Richard H Pin; Maura Reinblatt; Yuman Fong
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

7.  Experimental study of thymidine kinase gene therapy of neuroblastoma in vitro and in vivo.

Authors:  Xun Bi; Jing-Zhe Zhang
Journal:  Pediatr Surg Int       Date:  2003-07-05       Impact factor: 1.827

Review 8.  Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma.

Authors:  Bijay Dhungel; Aparna Jayachandran; Christopher J Layton; Jason C Steel
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 9.  Bacteriophage-derived vectors for targeted cancer gene therapy.

Authors:  Md Zahidul Islam Pranjol; Amin Hajitou
Journal:  Viruses       Date:  2015-01-19       Impact factor: 5.048

10.  Transcriptional Targeting in Cancer Gene Therapy.

Authors:  Tracy Robson; David G. Hirst
Journal:  J Biomed Biotechnol       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.